Source link : https://newshealth.biz/health-news/dupilumab-outperforms-omalizumab-in-high-biomarker-asthma/
Patients with asthma and chronic rhinosinusitis with nasal polyps derive greater benefit from dupilumab as eosinophil and fractional exhaled nitric oxide levels increase. Medscape Medical News Source link : https://www.medscape.com/viewarticle/high-type-2-biomarkers-identify-patients-most-likely-benefit-2026a1000khc?src=rss Author : Publish date : 2026-06-17 13:43:00 Copyright for syndicated content belongs to the linked Source.
The post Dupilumab Outperforms Omalizumab in High-Biomarker Asthma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-17 13:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8